Elena Crisa
Overview
Explore the profile of Elena Crisa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurnari C, Galossi E, Lumia E, Piciocchi A, Divona M, Casciani E, et al.
Br J Haematol
. 2024 Nov;
206(1):331-336.
PMID: 39533868
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) is a haemato-inflammatory syndrome genetically defined by somatic mutations in the X-linked UBA1 gene, typically Val/Thr/Leu substitutions at the Met41 hotspot. Clinical manifestations...
2.
Crisa E, Mora E, Germing U, Bally C, Diez Campelo M, Myllymaki M, et al.
Leukemia
. 2024 Aug;
38(10):2259-2265.
PMID: 39103678
Lenalidomide (LEN) can induce red blood cell-transfusion independence (RBC-TI) in 60-70% of del(5q) myelodysplastic neoplasm (MDS) patients. Current recommendation is to continue LEN in responding patients until failure or progression,...
3.
Lupia T, Crisa E, Sangiorgio V, Bosio R, Stroffolini G, Staffilano E, et al.
Infez Med
. 2024 Mar;
32(1):103-112.
PMID: 38456027
Toxocariasis is a zoonosis transmitted by the nematode spp. Immunocompromised hosts are more susceptible than general population to bacterial, viral, fungal and parasitic infections. In this population toxocariasis may present...
4.
Gurnari C, Koster L, Baaij L, Heiblig M, Yakoub-Agha I, Collin M, et al.
Blood Adv
. 2024 Feb;
8(6):1444-1448.
PMID: 38330178
No abstract available.
5.
Lupia T, Carnevale-Schianca F, Vita D, Busca A, Caravelli D, Crisa E, et al.
Medicina (Kaunas)
. 2024 Jan;
60(1).
PMID: 38256349
: is a ubiquitous, aerobic, Gram-negative bacillus causing increasing concern in patients affected by haematological malignancies. : We report a case series from two centres in Northern Italy to describe...
6.
Gurnari C, Pascale M, Vitale A, Diral E, Tomelleri A, Galossi E, et al.
Am J Hematol
. 2023 Dec;
99(2):254-262.
PMID: 38108611
VEXAS is a prototypic hemato-inflammatory disease combining rheumatologic and hematologic disorders in a molecularly defined nosological entity. In this nationwide study, we aimed at screenshotting the current diagnostic capabilities and...
7.
Lupia T, Crisa E, Gaviraghi A, Rizzello B, Di Vincenzo A, Carnevale-Schianca F, et al.
Trop Med Infect Dis
. 2023 Jul;
8(7).
PMID: 37505654
and cytomegalovirus co-infections are rarely reported, even though they are distinguished by high morbidity and mortality, especially in immunocompromised hosts. We narratively reviewed the literature on reported cases of and...
8.
Lupia T, Crisa E, Gaviraghi A, Rizzello B, Di Vincenzo A, Carnevale-Schianca F, et al.
Trop Med Infect Dis
. 2023 Jun;
8(6).
PMID: 37368749
To our knowledge, we have described the first case of /Cytomegalovirus (CMV) concomitant infection that occurred in a European country. The patient was a 76-year-old woman affected by relapsed non-Hodgkin...
9.
Tiribelli M, Latagliata R, Breccia M, Capodanno I, Miggiano M, Cavazzini F, et al.
Cancer
. 2023 Jun;
129(17):2637-2644.
PMID: 37354090
Background: Imatinib, dasatinib, and nilotinib are tyrosine kinase inhibitors (TKIs) approved in Italy for frontline treatment of chronic-phase chronic myeloid leukemia (CP-CML). The choice of TKI is based on a...
10.
Oliva E, Riva M, Niscola P, Santini V, Breccia M, Giai V, et al.
J Clin Oncol
. 2023 Jun;
41(28):4486-4496.
PMID: 37294914
Purpose: In myelodysplastic syndromes (MDS), severe thrombocytopenia is associated with poor prognosis. This multicenter trial presents the second-part long-term efficacy and safety results of eltrombopag in patients with low-risk MDS...